【Taixong】April 2026 Revenue 59.14 Million NTD (Year-on-Year +15.4%)
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
Taixong (4169), a biotechnology and medical company, reported April 2026 revenue of 59.14 million NTD, achieving a 15.4% year-over-year increase. This performance reflects strong growth and market penetration.